Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Autoimmune Disorders

Free Subscription 22.08.2022 3 BMC Neurol 5 Diabet Med 5 Diabetes Res Clin Pract 3 J Autoimmun 1 J Nephrol 1 J Neuroimmunol 3 J Rheumatol 1 Lancet Neurol 1 Mult Scler 1 Nat Rev Neurol 2 Neurologia (Engl Ed) 3 Neurology 3 PLoS One 2 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Neurol

1. LI T, Li Y, Li JW, Qin YH, et al
   Expression of TRAF6 in peripheral blood B cells of patients with myasthenia gravis.
   BMC Neurol. 2022;22:302.
   PubMed         Abstract available
   
   
2. VASANTHAPRASAD V, Khurana V, Vadapalle S, Palace J, et al
   Systematic literature review and meta-analysis of the prevalence of secondary progressive multiple sclerosis in the USA, Europe, Canada, Australia, and Brazil.
   BMC Neurol. 2022;22:301.
   PubMed         Abstract available
   
   
3. LI X, Sun M, Liu W, Liu N, et al
   Primary large B-cell lymphoma of the central nervous system with positive NMDAR antibody: a case report.
   BMC Neurol. 2022;22:298.
   PubMed         Abstract available
   
   

   
   Diabet Med

4. MESSER LH, Vigers T, Pyle L, Fivekiller E, et al
   Novel predictors of daily fluctuations in glycemia and self-management in adolescents and young adults with type 1 diabetes.
   Diabet Med. 2022 Jul 1:e14910. doi: 10.1111/dme.14910.
   PubMed         Abstract available
   
   
5. ROBERTS A, Fried L, Dart J, de Bock M, et al
   Hybrid closed loop therapy with a first-generation system increases confidence and independence in diabetes management in youth with Type 1 diabetes.
   Diabet Med. 2022 Jun 27:e14907. doi: 10.1111/dme.14907.
   PubMed         Abstract available
   
   
6. SONG SH, Frier BM
   Young-onset type 2 diabetes: a neglected group requiring urgent attention.
   Diabet Med. 2022 Jun 18:e14903. doi: 10.1111/dme.14903.
   PubMed        
   
   
7. DIVILLY P, Zaremba N, Mahmoudi Z, Soholm U, et al
   Hypo-METRICS: Hypoglycaemia-MEasurement, ThResholds and ImpaCtS-A multi-country clinical study to define the optimal threshold and duration of sensor-detected hypoglycaemia that impact the experience of hypoglycaemia, quality of life and health econom
   Diabet Med. 2022;39:e14892.
   PubMed         Abstract available
   
   
8. ARIF S, Yusuf N, Domingo-Vila C, Liu YF, et al
   Evaluating T cell responses prior to the onset of type 1 diabetes.
   Diabet Med. 2022 Apr 28:e14860. doi: 10.1111/dme.14860.
   PubMed         Abstract available
   
   

   
   Diabetes Res Clin Pract

9. MESA A, Gimenez M, Pueyo I, Perea V, et al
   Hyperglycemia and hypoglycemia exposure are differentially associated with micro- and macrovascular complications in adults with Type 1 Diabetes.
   Diabetes Res Clin Pract. 2022;189:109938.
   PubMed         Abstract available
   
   
10. RACCA C, Bouman EJ, Van Beers CAJ, Smits MM, et al
    Association between hypoglycaemic glucose variability and autonomic function in type1 diabetes with impaired hypoglycaemia awareness.
    Diabetes Res Clin Pract. 2022;189:109964.
    PubMed         Abstract available
    
    
11. PINTAUDI B, Gironi I, Disoteo O, Meneghini E, et al
    The effectiveness of a televisit service for people with type 1 diabetes: An observational, retrospective, single center, one year follow-up study.
    Diabetes Res Clin Pract. 2022;189:109960.
    PubMed         Abstract available
    
    
12. SAFI M, Borup A, Stevns Hansen C, Rossing P, et al
    Association between plasma apolipoprotein M and cardiac autonomic neuropathy in type 1 diabetes.
    Diabetes Res Clin Pract. 2022;189:109943.
    PubMed         Abstract available
    
    
13. DEHGHAN M, Ghorbani F, Najafi S, Ravaei N, et al
    Progress toward molecular therapy for diabetes mellitus: A focus on targeting inflammatory factors.
    Diabetes Res Clin Pract. 2022;189:109945.
    PubMed         Abstract available
    
    

    
    J Autoimmun

14. ARBITMAN L, Furie R, Vashistha H
    B cell-targeted therapies in systemic lupus erythematosus.
    J Autoimmun. 2022 Aug 10:102873. doi: 10.1016/j.jaut.2022.102873.
    PubMed         Abstract available
    
    
15. XU Y, Li P, Li K, Li N, et al
    Pathological mechanisms and crosstalk among different forms of cell death in systemic lupus erythematosus.
    J Autoimmun. 2022 Aug 10:102890. doi: 10.1016/j.jaut.2022.102890.
    PubMed         Abstract available
    
    
16. IZAGIRRE A, Arzallus T, Garmendia M, Torrente S, et al
    Autoimmune hepatitis following COVID-19 vaccination.
    J Autoimmun. 2022;132:102874.
    PubMed        
    
    

    
    J Nephrol

17. TAMPE D, Baier E, Hakroush S, Tampe B, et al
    Comparative analysis of complement C3 and C4 serum levels for outcome prediction in ANCA-associated renal vasculitis.
    J Nephrol. 2022 Aug 13. pii: 10.1007/s40620-022-01414.
    PubMed         Abstract available
    
    

    
    J Neuroimmunol

18. RACKE MK, Batish SD, Lisak RP, Barohn RJ, et al
    LRP4 antibody testing in myasthenia gravis.
    J Neuroimmunol. 2022;371:577949.
    PubMed        
    
    

    
    J Rheumatol

19. SCHLETZBAUM M, Kind AJ, Chen Y, Astor BC, et al
    Age-Stratified Thirty-Day Rehospitalization and Mortality and Predictors of Rehospitalization among Patients with Systemic Lupus Erythematosus: a Medicare cohort study.
    J Rheumatol. 2022 Aug 15. pii: jrheum.220025. doi: 10.3899/jrheum.220025.
    PubMed         Abstract available
    
    
20. CHUNG SH, Oshima K, Singleton M, Thomason J, et al
    Determinants of Cervical Cancer Screening Patterns Among Women with Systemic Lupus Erythematosus.
    J Rheumatol. 2022 Aug 15. pii: jrheum.220105. doi: 10.3899/jrheum.220105.
    PubMed         Abstract available
    
    
21. KIM YE, Choi SJ, Lim DH, Kim H, et al
    Disease Flare of Systemic Lupus Erythematosus in Patients With Endstage Renal Disease on Dialysis.
    J Rheumatol. 2022 Aug 15. pii: jrheum.220101. doi: 10.3899/jrheum.220101.
    PubMed         Abstract available
    
    

    
    Lancet Neurol

22. GORIS A, Vandebergh M, McCauley JL, Saarela J, et al
    Genetics of multiple sclerosis: lessons from polygenicity.
    Lancet Neurol. 2022;21:830-842.
    PubMed         Abstract available
    
    

    
    Mult Scler

23. IAFFALDANO P, Lucisano G, Guerra T, Patti F, et al
    Towards a validated definition of the clinical transition to secondary progressive multiple sclerosis: A study from the Italian MS Register.
    Mult Scler. 2022 Aug 15:13524585221114007. doi: 10.1177/13524585221114007.
    PubMed         Abstract available
    
    

    
    Nat Rev Neurol

24. HOFTBERGER R, Lassmann H, Berger T, Reindl M, et al
    Pathogenic autoantibodies in multiple sclerosis - from a simple idea to a complex concept.
    Nat Rev Neurol. 2022 Aug 15. pii: 10.1038/s41582-022-00700.
    PubMed         Abstract available
    
    

    
    Neurologia (Engl Ed)

25. SHAYGANNEJAD V, Mirmosayyeb O, Vaheb S, Nehzat N, et al
    The prevalence of sexual dysfunction (SD) and erectile dysfunction (ED) in men with multiple sclerosis (MS): a systematic review and meta-analysis.
    Neurologia (Engl Ed). 2022 Aug 10. pii: S2173-5808(22)00088.
    PubMed         Abstract available
    
    
26. GOMEZ-PINEDO U, Matias-Guiu JA, Torre-Fuentes L, Montero-Escribano P, et al
    Variant rs4149584 (R92Q) of the TNFRSF1A gene in patients with familial multiple sclerosis.
    Neurologia (Engl Ed). 2022 Aug 10. pii: S2173-5808(22)00087.
    PubMed         Abstract available
    
    

    
    Neurology

27. MCLAREN JR, Mitchell MK, Al-Maadid FM, Staley KJ, et al
    Clinical Reasoning: An 8-Year-Old With Acute Onset Ataxia.
    Neurology. 2022;99:305-310.
    PubMed         Abstract available
    
    
28. LEONHARD SE, van der Eijk AA, Andersen H, Antonini G, et al
    An International Perspective on Preceding Infections in Guillain-Barre Syndrome: The IGOS-1000 Cohort.
    Neurology. 2022 Aug 18. pii: WNL.0000000000200885.
    PubMed         Abstract available
    
    
29. ROOS I, Malpas C, Leray E, Casey R, et al
    Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis.
    Neurology. 2022 Aug 17. pii: WNL.0000000000201029.
    PubMed         Abstract available
    
    

    
    PLoS One

30. MAHMOUD RH, Fouad NA, Hefzy EM, Shaker OG, et al
    The potential role of serum expression profile of long non coding RNAs, Cox2 and HOTAIR as novel diagnostic biomarkers in systemic lupus erythematosus.
    PLoS One. 2022;17:e0268176.
    PubMed         Abstract available
    
    
31. MORRISON AE, Chong K, Senior PA, Lam A, et al
    A scoping review of Do-It-Yourself Automated Insulin Delivery system (DIY AID) use in people with type 1 diabetes.
    PLoS One. 2022;17:e0271096.
    PubMed         Abstract available
    
    
32. HOHN A, McGurnaghan SJ, Caparrotta TM, Jeyam A, et al
    Large socioeconomic gap in period life expectancy and life years spent with complications of diabetes in the Scottish population with type 1 diabetes, 2013-2018.
    PLoS One. 2022;17:e0271110.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

33. ZHU Z, Chen X, Wang C, Cheng L, et al
    Novel genes/loci validate the small effect size of ERBB2 in patients with myasthenia gravis.
    Proc Natl Acad Sci U S A. 2022;119:e2207273119.
    PubMed        
    
    
34. CHIA R, Saez-Atienzar S, Drachman DB, Traynor BJ, et al
    Reply to Zhu et al.: Implications of CHRNB1 and ERBB2 in the pathobiology of myasthenia gravis.
    Proc Natl Acad Sci U S A. 2022;119:e2209096119.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: